These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17428273)

  • 1. Implantable cardioverter-defibrillator shocks increase T-wave alternans.
    Lampert R; Soufer R; McPherson CA; Batsford WP; Tirado S; Earley C; Goldberg A; Shusterman V
    J Cardiovasc Electrophysiol; 2007 May; 18(5):512-7. PubMed ID: 17428273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes of T-wave alternans: does it predict short-term arrhythmia vulnerability?
    Kusmirek SL; Gold MR
    J Cardiovasc Electrophysiol; 2007 May; 18(5):518-9. PubMed ID: 17403082
    [No Abstract]   [Full Text] [Related]  

  • 3. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on the contribution by Lampert et al.
    Madias JE
    J Cardiovasc Electrophysiol; 2007 Sep; 18(9):E24; author reply E25. PubMed ID: 17680790
    [No Abstract]   [Full Text] [Related]  

  • 5. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
    Wierzbowski R; Michałkiewicz D; Cholewa M; Jacewicz K; Gniłka A; Adamus J
    Pol Merkur Lekarski; 2006 Oct; 21(124):310-3. PubMed ID: 17205766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA;
    J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
    Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of biventricular pacing on ventricular repolarization and functional indices in patients with heart failure: lack of association with arrhythmic events.
    Dilaveris P; Giannopoulos G; Synetos A; Aggeli C; Raftopoulos L; Arsenos P; Gatzoulis K; Stefanadis C
    Europace; 2009 Jun; 11(6):741-50. PubMed ID: 19376820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks.
    Gunderson BD; Abeyratne AI; Olson WH; Swerdlow CD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):157-65. PubMed ID: 17338710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upsurge in T-wave alternans and nonalternating repolarization instability precedes spontaneous initiation of ventricular tachyarrhythmias in humans.
    Shusterman V; Goldberg A; London B
    Circulation; 2006 Jun; 113(25):2880-7. PubMed ID: 16785339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anger-induced T-wave alternans predicts future ventricular arrhythmias in patients with implantable cardioverter-defibrillators.
    Lampert R; Shusterman V; Burg M; McPherson C; Batsford W; Goldberg A; Soufer R
    J Am Coll Cardiol; 2009 Mar; 53(9):774-8. PubMed ID: 19245968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions.
    Glikson M; Gurevitz OT; Trusty JM; Sharma V; Luria DM; Eldar M; Shen WK; Rea RF; Hammill SC; Friedman PA
    Am J Cardiol; 2004 Dec; 94(11):1445-9. PubMed ID: 15566924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute mental stress and exercise on T-wave alternans in patients with implantable cardioverter defibrillators and controls.
    Kop WJ; Krantz DS; Nearing BD; Gottdiener JS; Quigley JF; O'Callahan M; DelNegro AA; Friehling TD; Karasik P; Suchday S; Levine J; Verrier RL
    Circulation; 2004 Apr; 109(15):1864-9. PubMed ID: 15037524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms.
    Swerdlow C; Shivkumar K; Zhang J
    Circulation; 2003 Jun; 107(24):3028-33. PubMed ID: 12810611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs.
    Swerdlow CD; Shehata M; Chen PS
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):258-70. PubMed ID: 17338725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automatic determination of timing intervals for upper limit of vulnerability using ICD electrograms.
    Shehata M; Belk P; Kremers M; Saba S; Cao J; Swerdlow CD
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):691-700. PubMed ID: 18507541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.